Your session is about to expire
← Back to Search
Administration of CC-97540 (PMS arm) for Multiple Sclerosis
Study Summary
This trial aims to test the safety, effectiveness, and drug levels of CC-97540 in people with either Relapsing Forms or Progressive Forms of Multiple Sclerosis.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this research study have an age limit for potential participants, specifically individuals who are 50 years old or older?
"In order to be considered for participation in this trial, individuals must meet the age requirement of being at least 18 years old and no older than 65 years."
Which individuals are considered the most suitable candidates to participate in this research study?
"To be eligible for participation in this clinical trial, prospective patients must have a diagnosis of multiple sclerosis and fall within the age range of 18 to 65 years old. The study aims to enroll approximately 98 individuals."
Are there any ongoing efforts to enlist participants for this research study at the moment?
"As per the information available on clinicaltrials.gov, this study is not currently seeking participants. The trial was initially posted on January 15th, 2024, and most recently updated on January 22nd, 2024. However, it's worth noting that there are presently 530 other ongoing clinical trials actively enrolling patients at this time."
Has the Food and Drug Administration officially authorized the use of CC-97540 (RMS arm) as a treatment option?
"This trial is categorized as a Phase 1 study, suggesting that there is limited evidence available to support the safety and effectiveness of administering CC-97540 (RMS arm). As a result, our team at Power assigns it a safety rating of 1."
At how many different venues is this experimental investigation currently being supervised?
"To minimize travel requirements for participants, it is advisable to select the trial site that is geographically closest. This study currently operates in 20 different locations, including Manchester, Philadelphia, València, and various other cities."
Share this study with friends
Copy Link
Messenger